SCHEMBL8926767

SCHEMBL8926767

C=CC(N)C1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7166980 1.00
Hydrochloric Acid SCHEMBL2773491 0.97
SCHEMBL538846 0.88
SCHEMBL9387320 0.88
SCHEMBL176076 0.86 EPHX1 (0.39)
SCHEMBL10482352 0.85
Hydrochloric Acid SCHEMBL4416986 0.84 KDM4E (0.38)
Hydrochloric Acid SCHEMBL4409590 0.84 KDM4E (0.38)
SCHEMBL7859411 0.82
SCHEMBL4019377 0.82 DPP4 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210395185-A1 SCALABLE SYNTHESIS OF OPTICALLY ACTIVE 1-CYCLOPROPYLALKYL-1-AMINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2021-12-23 US claimed
WO-2020079145-A1 SCALABLE SYNTHESIS OF OPTICALLY ACTIVE 1-CYCLOPROPYLALKYL-1-AMINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2020-04-23 WO claimed
CN-111434665-B Ensultamidenamide-arylamide compounds and their use for treating hepatitis B 上海长森药业有限公司 2023-03-10 CN disclosed
CN-113286798-A Ensultiamidinamide-aryl amide compound and application thereof in treating hepatitis B 上海长森药业有限公司 2021-08-20 CN disclosed
CN-111434665-A Ensultiamidinamide-aryl amide compound and application thereof in treating hepatitis B 上海长森药业有限公司 2020-07-21 CN disclosed
CN-110520406-A Cyclopropyl pheynylalkylamine and preparation method thereof BOEHRINGER INGELHEIM INT 2019-11-29 CN disclosed
US-8431569-B2 Inhibitors of janus kinases MERCK SHARP & DOHME CORP. (US) 2013-04-30 US disclosed
US-8431569-B2 Inhibitors of janus kinases MERCK SHARP & DOHME CORP. (US) 2013-04-30 US disclosed
US-20100267709-A1 INHIBITORS OF JANUS KINASES MERCK SHARP & DOHME LLC 2010-10-21 US disclosed
US-5621142-A N-METHYLASPARATIC ACID ANTAGONIST ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1997-04-15 US disclosed
US-5621142-A N-METHYLASPARATIC ACID ANTAGONIST ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1997-04-15 US disclosed
US-5621142-A N-METHYLASPARATIC ACID ANTAGONIST ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1997-04-15 US disclosed
EP-0747348-A1 AMINOALKYLCYCLOPROPANE DERIVATIVE Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1996-12-11 EP disclosed
EP-0747348-A1 AMINOALKYLCYCLOPROPANE DERIVATIVE Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1996-12-11 EP disclosed
CN-1079745-A New 9-fluoro-7-oxo-7H-pyrido [1,2,3-d, e] [1,4] benzoxazine-6-carboxylic acids and ester thereof BAYER AG (DE) 1993-12-22 CN disclosed
EP-0563734-A1 9-fluoro-7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazine carboxylic acids and esters and their use as antiviral agents BAYER AG (DE) 1993-10-06 EP disclosed